These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 6146148)

  • 1. [Clinical evaluation of caeruletide (883-S) in chronic schizophrenia].
    Kudo Y
    Seishin Shinkeigaku Zasshi; 1983; 85(11):797-801. PubMed ID: 6146148
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antipsychotic effects of caerulein on chronic schizophrenia].
    Moroharu T; Watanabe N; Ito M
    Seishin Shinkeigaku Zasshi; 1983; 85(9):611-5. PubMed ID: 6145173
    [No Abstract]   [Full Text] [Related]  

  • 3. Is cholecystokinin therapeutic in chronic schizophrenia?
    Boza RA; Rotondo DJ
    J Clin Psychiatry; 1985 Nov; 46(11):485-6. PubMed ID: 3902807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence of antipsychotic effect of caerulein in schizophrenic patients free of neuroleptics: a double-blind cross-over study.
    Lotstra F; Verbanck P; Mendlewicz J; Vanderhaeghen JJ
    Biol Psychiatry; 1984 Jun; 19(6):877-82. PubMed ID: 6378259
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical evaluation of ceruletide in schizophrenia: a multi-institutional cooperative double-blind controlled study.
    Itoh H; Shimazono Y; Kawakita Y; Kudo Y; Satoh Y; Takahashi R
    Psychopharmacol Bull; 1986; 22(1):123-8. PubMed ID: 3523572
    [No Abstract]   [Full Text] [Related]  

  • 6. [Parenteral form of pipothiazine in the treatment of endogenous psychoses].
    Matkowski K; Martenka E; Nobis T
    Psychiatr Pol; 1984; 18(6):567-70. PubMed ID: 6152666
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacologic treatment of adolescent and child schizophrenia.
    Young CM; Findling RL
    Expert Rev Neurother; 2004 Jan; 4(1):53-60. PubMed ID: 15853615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in the eye movements of chronic schizophrenics as a result of treatment with a CCK-8-like drug (caerulein)].
    Sudo K; Koyama T; Ichikawa J; Yasuda M; Kazawa T
    Seishin Shinkeigaku Zasshi; 1983; 85(11):805-7. PubMed ID: 6677916
    [No Abstract]   [Full Text] [Related]  

  • 9. The first clinical study of BW-234U in schizophrenia.
    Davidson J; Miller R; Wingfield M; Zung W; Dren AT
    Psychopharmacol Bull; 1982 Oct; 18(4):173-6. PubMed ID: 6130560
    [No Abstract]   [Full Text] [Related]  

  • 10. [Schizophrenic with obsessive-compulsive disorder or symptoms].
    Doubremelle C; Millet B; Olie JP
    Encephale; 2000; 26(2):81-8. PubMed ID: 10858921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone for chronic schizophrenia.
    Med Lett Drugs Ther; 1994 Apr; 36(920):33-4. PubMed ID: 7511777
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment and outcomes in adolescents with schizophrenia.
    Schulz SC; Findling RL; Friedman L; Kenny JT; Wise AL
    J Clin Psychiatry; 1998; 59 Suppl 1():50-4; discussion 55-6. PubMed ID: 9448669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability.
    Thyssen A; Remmerie B; D'Hoore P; Kushner S; Mannaert E
    Clin Ther; 2007 Feb; 29(2):290-304. PubMed ID: 17472821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book.
    Mishara AL; Goldberg TE
    Biol Psychiatry; 2004 May; 55(10):1013-22. PubMed ID: 15121486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceruletide for schizophrenia: a review.
    Mattes JA; Hom W; Rochford JM
    Psychopharmacol Bull; 1986; 22(1):119-22. PubMed ID: 3523571
    [No Abstract]   [Full Text] [Related]  

  • 16. Introduction: evaluating clinical trial data from schizophrenia research.
    Tamminga CA
    J Clin Psychiatry; 2001; 62 Suppl 9():3-4. PubMed ID: 11379829
    [No Abstract]   [Full Text] [Related]  

  • 17. Introduction: evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond.
    Nasrallah HA
    J Clin Psychiatry; 2007; 68 Suppl 1():3-4. PubMed ID: 17286521
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose selection and comparator drugs in schizophrenia research.
    Kane JM
    J Clin Psychiatry; 2001; 62 Suppl 9():29-32; discussion 33-4. PubMed ID: 11379828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sertindole, a new atypical antipsychotic for the treatment of schizophrenia.
    Brown LA; Levin GM
    Pharmacotherapy; 1998; 18(1):69-83. PubMed ID: 9469684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction. Ziprasidone in schizophrenia: from acute treatment to long-term management.
    Kane JM
    J Clin Psychiatry; 2003; 64 Suppl 19():3-5. PubMed ID: 14728083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.